PI3K/AKT signaling activity plays a central role in NSCLC progression with the activation of AKT ultimately inhibiting the pro-apoptotic Bcl-2 family proteins Bax and Bad [28]. This evidence concerns the gene PIK3CD and non-small cell lung carcinoma.